SAN DIEGO, CA , June 17, 2021 – Multimeric Biotherapeutics, Inc., a biotechnology company developing vaccines against cancer and infectious diseases, announced today that it has been accepted to present at the Keystone Symposium on Innovative Vaccine Approaches. The meeting will be held as a virtual web conference scheduled June 28-30, 2021.
Richard S. Kornbluth, MD, PhD, President & Chief Scientific Officer will present an overview of Multimeric’s new vaccine platform (FortiVacTM) that elicits very strong CD8+ T cell responses against the chosen antigen. The Company will present a poster and give a short talk about the technology.
A link to the poster can be found here.